Navigation Links
Intrexon Announces Third Quarter Financial Results
Date:11/7/2013

, for each of the periods indicated:Three months endedNine months endedSeptember 30,September 30,2013201220132012(In thousands)Pro forma adjusted EBITDA per share:Numerator:Adjusted EBITDA (in thousands)$

(5,092)$

(14,129)$

(16,576)$

(49,470)Denominator (1) (2):Pro forma weighted average common shares used in computing pro forma adjusted EBITDA per share, basic and diluted91,558,83870,170,71783,738,32768,969,293Pro forma adjusted EBITDA per share, basic and diluted$

(0.06)$

(0.20)$

(0.20)$

(0.72)(1)
Pro forma adjusted EBITDA  per share, basic and diluted have been calculated for the three and nine month periods ended September 30, 2013 after giving effect to (i) the conversion of 112,906,464  shares of our preferred stock outstanding on January 1, 2013 into 64,517,977 shares of common stock upon the completion of our initial public offering; (ii) the issuance of 19,047,619 shares of Series F preferred stock issued between January 1, 2013 and April 30, 2013 and the conversion of those shares into 10,884,353 shares of our common stock upon the completion of our initial public offering; and (iii) the conversion upon the completion of our initial public offering of aggregate cumulative dividends on our preferred stock of $68.8 million into 4,302,800 shares of our common stock at the initial public offering price of $16.00 per share. 

(2)
Pro forma adjusted EBITDA per share, basic and diluted have been calculated for the three and nine month periods ended September 30, 2012 after giving effect to (i) the conversion of 97,096,941 shares of our preferred stock outstanding on January 1, 2012 into 55,483,966  shares of our common stock upon the completion of our initial public offering; (ii) the issuance of 11,047,618 shares of Series E preferred stock issued between January 1, 2012 and September 30, 2012 and the conversion of those shares into 6,312,924 s
'/>"/>

SOURCE Intrexon Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Soligenix and Intrexon Pursue Melioidosis Therapy Through Worldwide Exclusive Collaboration
2. Misonix, Inc. Announces First Quarter Fiscal Year 2014 Financial Results
3. Pro-Dex, Inc. Announces Fiscal 2014 First Quarter Financial Results Conference Call And Webcast
4. DURECT Announces Proposed Public Offering of Common Stock
5. Cellular Biomedicine Group Announces November 07, 2013 as Voting Deadline for Its Annual Shareholder Meeting
6. Star Scientific Announces Leadership Transition, Acceleration of Plans for Submission of an IND to FDA for Pharmaceutical Version of Anatabine Compound
7. Echo Therapeutics Announces Third Quarter 2013 Financial Results
8. Regado Biosciences, Inc. Announces Third Quarter 2013 Results
9. PDL BioPharma Announces Third Quarter 2013 Financial Results
10. Regulus Announces Timing for Third Quarter 2013 Financial Results Webcast and Conference Call
11. Heska Announces Financial Results for the Third Quarter of Fiscal 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... SAN DIEGO, July 30, 2015  ResMed Inc. (NYSE: ... ended June 30, 2015.  Revenue for the quarter was ... quarter ended June 30, 2014 (a 17 percent increase ... million, consistent with the quarter ended June 30, 2014. ... consistent with the quarter ended June 30, 2014.  ...
(Date:7/30/2015)... Calif. , July 30, 2015  EP ... /Alcon executives have recently contacted the Company about ... begin as early as Monday, August 3, 2015.  ... quoted as saying that the coming electronic contact ... of dollars over the next several years.  Novartis ...
(Date:7/30/2015)... N.J. , July 30, 2015  Unichem Pharmaceuticals ... recalling one lot of Hydrochlorothiazide tablets 25 mg 1000-count ... initiated as a precautionary measure due to the identification ... the product. The risk associated with ... tablet is the increased probability of experiencing Clopidogrel,s side ...
Breaking Medicine Technology:ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 3ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 4ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 5ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 7ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 8ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 9ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 10ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 11ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 12ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 13ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 14ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 15ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 16Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2
... American Pharmacists Month and CVS Caremark is recognizing ... their patients every day in its retail pharmacies, ... country. (Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO) (Logo: ... time to recognize the significant contributions to health ...
... pharmaceutical and biotechnology sectors have long turned to the ... landscape. As the marketplace has evolved, leading organizations have ... as well. Specifically, effective market research groups ... one involved with shaping strategic objectives for key commercial ...
Cached Medicine Technology:CVS Caremark Recognizes Its 26,000 Pharmacists During October's American Pharmacists Month 2Best Practices, LLC Research Highlights Evolving Role of Market Research in Organizational Success 2
(Date:7/30/2015)... ... ... Using the latest online digital technologies, happiness expert Kay Walker is on ... manage major depression. , “Suicide is 100% preventable. The problem is the medical community ... die needlessly everyday,” says Walker. “I’m out to end suicide. Some may say that’s ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... On July ... $2 billion in taxpayer money to fund the state’s large prison system, which has ... with the highest rates of incarceration. In light of President Obama’s recent reduction of ...
(Date:7/30/2015)... ... 30, 2015 , ... Ocean Hills Recovery has officially been accredited by CARF ... No recommendations means CARF found no areas in the OHR program that needed improvement, ... of all facilities receive. In addition, Ocean Hills was granted the maximum certification period ...
(Date:7/30/2015)... ... July 30, 2015 , ... The ... of the New Jersey Department of Health, has received a $2.9 million grant ... of the U.S. Department of Health and Human Services (HHS). NJII will help ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... InventHelp, ... from Texas, has designed a personal-care device that makes it easy to apply lotion ... could eliminate the need for assistance when applying lotion or medication to the back, ...
Breaking Medicine News(10 mins):Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 2Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 3Health News:Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders 2Health News:Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders 3Health News:Ocean Hills Recovery Receives Accreditation from CARF International 2Health News:New Jersey Innovation Institute Awarded $2.9 Million Federal Grant to Advance Health Information Technology Services to Support Health Information Exchange 2Health News:InventHelp® Client Patents “My Back Buddy” – Device Could Apply Lotion to Hard-to-Reach Areas Easily 2
... Even non-obese people are at risk, researchers find , WEDNESDAY, ... major risk factor for obstructive sleep apnea, many non-obese people ... new study. , Among 5,426 non-obese adults (with a body-mass ... present in 54 percent. About half of those with the ...
... key target of an evolutionarily conserved protein that regulates ... in Nature , provides fundamental knowledge about key ... strategies and cancer therapies. Scientists have long ... fitness and longevity in most organisms ranging from single-celled ...
... Four suspects often found at the scene of the crime in ... in mice that are resistant to the disease, a team led ... Center reports in the June edition of Cancer Cell . ... the three protein receptors and the enzyme that makes them are ...
... June 10 As more and more employees become eligible ... and smaller percentage of them are actually signing up for ... of the Spencer,s Benefits Reports 2009 COBRA Survey. ... the 2008 plan year at companies covered by the survey, ...
... Seroquel, Zyprexa have been linked to certain health ... News) -- A U.S. Food and Drug Administration ... whether several powerful but controversial antipsychotic drugs be ... in question include new-generation "atypical" antipsychotics such as ...
... Education Newsletter Series for Healthcare Professionals , , ... syndrome characterized by localized, subcutaneous and/or submucosal swelling. Diagnosing ... there are multiple etiologies of this condition, all of ... healthcare professionals to understand the various causes of angioedema, ...
Cached Medicine News:Health News:Wistar Institute team finds key target of aging regulator 2Health News:Researchers identify four new targets for breast cancer 2Health News:Spencer's Benefits Reports COBRA Survey Finds Recession Takes Hold: More Were Eligible, Fewer Signed Up, Costs Stay High 2Health News:Spencer's Benefits Reports COBRA Survey Finds Recession Takes Hold: More Were Eligible, Fewer Signed Up, Costs Stay High 3Health News:Spencer's Benefits Reports COBRA Survey Finds Recession Takes Hold: More Were Eligible, Fewer Signed Up, Costs Stay High 4Health News:FDA Panel Mulls Newer Antipsychotics for Kids 2Health News:FDA Panel Mulls Newer Antipsychotics for Kids 3Health News:FDA Panel Mulls Newer Antipsychotics for Kids 4Health News:New Directions in Angioedema: A Focus on Etiologies and Clinical Approach 2
... communications software, including Remote Link and Central ... you the tools and choices to effectively ... Send patient tests via email, LAN or ... Philips Zymed Holter analysis applications are used. ...
... 12 gives you the detailed information you ... for your patients with palpitations, syncope and ... EASI Lead System, this transtelephonic cardiac event ... a derived 12-lead ECG. Comfortable for your ...
... the Zargis Acoustic Cardioscan Viewer Phonocardiogram (PCG). ... system that allows you to record, condition, ... an electronic stethoscope. The product acquires ... of up to four sites, and allows ...
... with the challenge of,controlling costs while ... patient data,management is critical. INFINITY modular,patient ... important clinical information,wherever you are in ... concept,makes your job easier. You can ...
Medicine Products: